MiMedx to Feature Two Spinal Surgery Products

MiMedx has announced it will be featuring two technologies focused on spinal surgery at the upcoming SAS — The International Society for the Advancement of Spine Surgery Annual Meeting, according to a company news release.

Advertisement

MiMedx will highlight its HydroFix Vaso Shield and AmnioFix Amniotic Membrane Allografts. The HydroFix Vaso Shield is an FDA-approved device designed for vessel protection during anterior vertebral surgery. MiMedx’s AmnioFix is processed from the human amniotic membrane through proprietary technology to produce an implant that is safe, effective and minimally manipulated.

Read the news release about MiMedx’s orthopedic and spine products.

Read other coverage about MiMedx:

MiMedx Group Acquires Surgical Biologics

MiMedx Receives FDA Clearance for HydroFix Vaso Shield

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.